COVID-19 swiftly changed the healthcare landscape around the world. There has been no rulebook for pharmaceutical commercialization during COVID-19. Pharmaceutical commercialization teams have had to quickly adapt to meet customer, community and business needs. Remote customer engagement and increased patient support services were the answer in the short term for pharmaceutical commercialization amid COVID-19. Longer term, teams will need to adapt brand strategy and executional approaches for in-line and launch brands to meet the new reality of customer and business needs during the ongoing pandemic.
This webinar will cover the actions that pharmaceutical commercial teams can take now to stay on track with 2020 goals and to plan for 2021. Pharmaceutical and biotech commercialization teams will hear about trends in the marketplace during the last few months of marketing, medical affairs, market access strategy and customer communication during COVID-19. We will discuss the choices teams have made and the rationale for different approaches. Whether you are seeking to re-start pharmaceutical commercialization or planning for a new launch, the short and long-term planning guidance discussed will be of value.
The world-wide Coronavirus pandemic is a generational event that is challenging business leaders in unprecedented ways. The coming months will undoubtedly test the US economy and our ability to lead our teams and organizations to accomplish our commercial goals.
We want you to know that Herspiegel Consulting is fully operational and committed to helping your organization remain productive. As your business partner, we are accustomed to achieving demanding business goals in a variety of working environments. While your organization transitions to a remote workplace for the weeks or months ahead, our skills in strategic management, virtual team operation, and project implementation can help you ensure that key strategic initiatives stay on track and that new workstreams begin so that your business goals don’t suffer.
We look forward to supporting you during the challenging months ahead.